Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren
- PMID: 39493254
- PMCID: PMC11528602
- DOI: 10.1177/25158414241294024
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren
Abstract
Background: Sjögren's syndrome is an autoimmune disease characterized by sicca symptoms and various extraglandular manifestations including vasculitis. Neurological involvement occurs frequently (Neuro-Sjögren) and often mimics immune neuropathies such as chronic inflammatory demyelinating polyneuropathy (CIDP).
Objectives: We aim to assess relevant differences in vessel density (VD) in Optical Coherence Tomography Angiography (OCTA) in those diseases to use it as an easily available diagnostic tool.
Design: Prospective, monocentric pilot-study.
Methods: OCTA (Heidelberg Engineering OCT SPECTRALIS) of the superficial vascular plexus, intermediate capillary plexus (ICP) and deep capillary plexus (DCP) of the retina was prospectively performed in Neuro-Sjögren, age-matched CIDP patients (n = 31, each), and healthy controls (n = 30). Vessel density (VD) and foveal avascular zone (FAZ) was measured with Erlangen Angio Tool.
Results: Significantly lower VD were found for the DCP and ICP in Neuro-Sjögren and CIDP patients compared to healthy controls (p = 0.0002 and <0.0001). When group comparison was age-adjusted, these differences were not found anymore. Different frequencies of "low" retinal blood flow in each layer comparing Neuro-Sjögren and CIDP patients were not found. FAZ revealed no significant differences between patients with Neuro-Sjögren, CIDP and healthy controls.
Conclusion: This study found no significant differences in VD or the foveal avascular zone between Neuro-Sjögren and CIDP patients using OCTA, suggesting that inflammatory vascular changes in the retina are uncommon in Neuro-Sjögren patients.
Keywords: Sjögren’s syndrome; chronic inflammatory demyelinating polyneuropathy; neuro-Sjögren; optical coherence tomography angiography; retinal vasculature; vasculitis.
© The Author(s) 2024.
Figures
References
-
- Seror R, Theander E, Brun JG, et al.. EULAR Sjögren’s Task Force. Validation of EULAR primary Sjögren’s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 2015; 74(5): 859–866. - PubMed
-
- Pindi Sala T, Villedieu M, Damian L, et al.. Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sjögren’s syndrome. J Neurol 2020; 267(12): 3499–3507. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
